- €104.34m
- €75.14m
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 34.9 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 7.5 | — | — | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 47.2 | 5.7 | 5.1 | 3.8 | 4.5 |
Operating Profit | -12.3 | -5.7 | -5.1 | -3.8 | -4.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.5 | 92 | -3.8 | 12.3 | 0 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.2 | 88.4 | -0.5 | 12.9 | 0 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -5.4 | 87.7 | 37.8 | 12.9 | 0 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.4 | 87.7 | 37.8 | 12.9 | 0 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.142 | 1.91 | 0.054 | 0.435 | 0.027 |